These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 20587671)

  • 21. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
    Muhsen K; Chodick G; Goren S; Shalev V; Cohen D
    Vaccine; 2010 Dec; 29(1):91-4. PubMed ID: 20969927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium.
    Raes M; Strens D; Vergison A; Verghote M; Standaert B
    Pediatr Infect Dis J; 2011 Jul; 30(7):e120-5. PubMed ID: 21436757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.
    Curns AT; Coffin F; Glasser JW; Glass RI; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S49-56. PubMed ID: 19817614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents.
    Eberly MD; Gorman GH; Eide MB; Olsen CH; Rajnik M
    Vaccine; 2011 Jan; 29(4):650-9. PubMed ID: 21129394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.
    Weycker D; Atwood MA; Standaert B; Krishnarajah G
    Hum Vaccin Immunother; 2014; 10(7):2032-8. PubMed ID: 25424813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in rotavirus after vaccine introduction--United States, 2000-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1146-9. PubMed ID: 19847149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children <5 years of age, 2007-2008.
    Muhsen K; Shulman L; Rubinstein U; Kasem E; Kremer A; Goren S; Zilberstein I; Chodick G; Ephros M; Cohen D;
    J Infect Dis; 2009 Nov; 200 Suppl 1():S254-63. PubMed ID: 19817606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine.
    Tate JE; Panozzo CA; Payne DC; Patel MM; Cortese MM; Fowlkes AL; Parashar UD
    Pediatrics; 2009 Aug; 124(2):465-71. PubMed ID: 19581260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.